VANCOMYCIN DOSAGE OPTIMIZATION IN PEDIATRIC PATIENTS WITH SOLID TUMOR DISEASE BY POPULATION PHARMACOKINETIC ANALYSIS

被引：0
|
作者：
Guilhaumou, R. [1 ]
Marsot, A. [1 ]
Rome, A. [1 ]
Boulamery, A. [1 ]
Simon, N. [1 ]
Andre, N. [1 ]
机构：
[1] Hop Enfants La Timone, Marseille, France
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [1] Vancomycin dosage optimization in pediatric patients with solid tumor disease by population pharmacokinetics analysis
    Guilhaumou, R.
    Marsot, A.
    Buffet-Delmas, P.
    Rome, A.
    Boulamery, A.
    Andre, N.
    Simon, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 70 - 71
  • [2] Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization
    Guilhaumou, Romain
    Marsot, Amelie
    Dupouey, Julien
    Galambrun, Claire
    Boulamery, Audrey
    Coze, Carole
    Simon, Nicolas
    Andre, Nicolas
    THERAPEUTIC DRUG MONITORING, 2016, 38 (05) : 559 - 566
  • [3] Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis
    del Mar Fernandez de Gatta, Maria
    Santos Buelga, Dolores
    Sanchez Navarro, Amparo
    Dominguez-Gil, Alfonso
    Jose Garcia, Maria
    CLINICAL PHARMACOKINETICS, 2009, 48 (04) : 273 - 280
  • [4] Initial dosage regimens of vancomycin for Chinese adult patients based on population pharmacokinetic analysis
    Deng, Chenhui
    Liu, Taotao
    Zhou, Tianyan
    Lu, Hua
    Cheng, Daohai
    Zhong, Xiaobing
    Lu, Wei
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (05) : 407 - 415
  • [5] Vancomycin in Pediatric Patients with Cystic Fibrosis: Dose Optimization Using Population Pharmacokinetic Approach
    Yaliniz, Aysenur
    Blouin, Mathieu
    Metras, Marie-elaine
    Boulanger, Marie-Christine
    Cloutier, Karine
    Dube, Marie-Helene
    Autmizguine, Julie
    Marsot, Amelie
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (06) : 677 - 687
  • [6] Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokineticpharmacodynamic analysis
    Gatta M.D.M.F.D.
    Buelga D.S.
    Navarro A.S.
    Dominguez-Gil A.
    García M.J.
    Clinical Pharmacokinetics, 2009, 48 (4) : 273 - 280
  • [7] Dosage Optimization of Digoxin in Older Patients with Heart Failure and Chronic Kidney Disease: A Population Pharmacokinetic Analysis
    Zhong-Qiu Lin
    Ling Guo
    Li-Min Zhang
    Jie-Jiu Lu
    Xia Jiang
    Drugs & Aging, 2023, 40 : 539 - 549
  • [8] Dosage Optimization of Digoxin in Older Patients with Heart Failure and Chronic Kidney Disease: A Population Pharmacokinetic Analysis
    Lin, Zhong-Qiu
    Guo, Ling
    Zhang, Li-Min
    Lu, Jie-Jiu
    Jiang, Xia
    DRUGS & AGING, 2023, 40 (06) : 539 - 549
  • [9] Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens
    Amélie Marsot
    F. Gallais
    C. Galambrun
    C. Coze
    O. Blin
    N. Andre
    R. Guilhaumou
    Pediatric Drugs, 2018, 20 : 375 - 381
  • [10] Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens
    Marsot, Amelie
    Gallais, F.
    Galambrun, C.
    Coze, C.
    Blin, O.
    Andre, N.
    Guilhaumou, R.
    PEDIATRIC DRUGS, 2018, 20 (04) : 375 - 381
12345